When should contact precautions and active surveillance be used to manage patients with multidrug-resistant enterobacteriaceae?

Infection Control and Hospital Epidemiology

Volumn 33, Issue 7, 2012, Pages 753-756

  Freeman, Joshua T ^a   Williamson, Deborah A ^a   Anderson, Deverick J ^b  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE SURVEILLANCE; ARTICLE; CONCEPTUAL FRAMEWORK; CONTACT PRECAUTION; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; ENTEROBACTERIACEAE; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL PATIENT; HUMAN; INFECTION CONTROL; MULTIDRUG RESISTANT ENTEROBACTERIACEAE; PATIENT CARE;

CROSS INFECTION; DRUG RESISTANCE, MULTIPLE; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; INFECTION CONTROL; POPULATION SURVEILLANCE;

EID: 84863223406     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/666333     Document Type: Article

References (37)

1. Peleg A, Hooper D. Hospital-acquired infections due to gramnegative bacteria. N Engl J Med 2010;362:1804-1813.
2. Chen YH, Hsueh PR, Badal RE, et al. Antimicrobial susceptibility profiles of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria. J Infect 2011;62(4):280-291.
3. Cantón R, Coque TM. The CTX-M b-lactamase pandemic. Curr Opin Microbiol 2006;9:466-475.
4. Carratoli A. Resistance plasmid families in Enterobacteriaceae. Antimicrob Agents Chemother 2009;53:2227-2238.
5. Woodford N. Successful, multiresistant bacterial clones. J Antimicrob Chemother 2008;61:233-234.
6. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. Atlanta: Centers for Disease Control and Prevention, 2007.
7. Srinivasan A, Song X, Ross T, et al. A prospective study to determine whether cover gowns in addition to gloves decrease nosocomial transmission of vancomycin-resistant enterococci in an intensive care unit. Infect Control Hosp Epidemiol 2002;23: 424-428.
8. Snyder GM, Thom KA, Furuno JP, et al. Detection of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on the gowns and gloves of healthcare workers. Infect Control Hosp Epidemiol 2008;29:583-589.
9. Aboelela SW, Saiman L, Stone P, et al. Effectiveness of barrier precautions and active surveillance cultures to control transmission of multidrug-resistant organisms: a systematic review of the literature. Am J Infect Control 2006;34:484-494.
10. Spence MR, Dammel T, Courser S. Contact precautions for methicillin-resistant Staphylococcus aureus colonization: costly and unnecessary? Am J Infect Control doi:10.1016/j.ajic.2011.07.016. Published October 19, 2011.
11. Langer AJ, Lafaro P, Genese CA, McDonough P, Nahass R, Robertson C. Using active surveillance and enhanced infection control measures to control an outbreak of health care-associated extended spectrum beta-lactamase-producing Klebsiella pneumoniae infections-New Jersey, 2007. Am J Infect Control 2009;37:73-75.
12. Laurent C, Rodriguez-Villabos H, Rost F, et al. Intensive care unit outbreak of extended-spectrum b-lactamase-producing Klebsiella pneumoniae controlled by cohorting patients and reinforcing infection control measures. Infect Control Hosp Epidemiol 2008;29:517-524.
13. Kola A, Holst M, Chaberny S, Ziesing S, Suerbaum S, Gastmeier P. Surveillance of extended-spectrum b-lactamase-producing bacteria and routine use of contact isolation: experience from a three-year period. J Hosp Infect 2007;66:46-51.
14. Conterno LO, Shymanski J, Ramotar K, Toye B, Zvonar R, Roth V. Impact and cost of infection control measures to reduce nosocomial transmission of extended-spectrum b-lactamaseproducing organisms in a non-outbreak setting. J Hosp Infect 2007;65:354-360.
15. Morgan DJ, Diekema DJ, Sepkowitz K, Perencevich EN. Adverse outcomes associated with contact precautions: a review of the literature. Am J Infect Control 2009;37:85-93.
16. Thouverez M, Talon D, Bertrand X. Control of Enterobacteriaceae producing extended-spectrum beta-lactamase in intensive care units: rectal screening may not be needed in non-epidemic situations. Infect Control Hosp Epidemiol 2004;25:838-841.
17. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010;10:597-602.
18. Laupland KB, Kirkpatrick AW, Church DL, Ross T, Gregson DB. Intensive-care-unit-acquired bloodstream infections in a regional critically ill population. J Hosp Infect 2004;58:137-145.
19. Harris AD, McGregor JC, Furuno JP. What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria? Clin Infect Dis 2006;43:S57-S61.
20. Gardam MA, Burrows LL, Kus JV, et al. Is surveillance for multidrug-resistant Enterobacteriaceae an effective infection control strategy in the absence of an outbreak? J Infect Dis 2002;186:1754-1760.
21. Anderson B, Nicholas S, Sprague B, et al. Molecular and descriptive epidemiology of multidrug-resistant Enterobacteriaceae in hospitalized infants. Infect Control Hosp Epidemiol 2008;29:250-255.
22. Harris AD, Koteshvili M, Shurland S, et al. How important is patient-to-patient transmission in extended-spectrum b-lactamase Escherichia coli acquisition? Am J Infect Control 2007;35: 97-101.
23. Harris AD, Perencevich EN, Johnson JK, et al. Patient-topatient transmission is important in extended-spectrum blactamase-producing Klebsiella pneumoniae acquisition. Clin Infect Dis 2007;45;1347-1350.
24. Freeman JT, McBride SJ, Heffernan H, et al. Community-onset genitourinary tract infection due to CTX-M-15-producing Escherichia coli among travelers to the Indian subcontinent in New Zealand. Clin Infect Dis 2008;47:689-692.
25. Ben Ami R, Schwaber MJ, Nanon-Venezia S, et al. Influx of extended-spectrum b-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 2006;42:925-934.
26. Tängdén T, Cars O, Melhus A, Löwdin E. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum b-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother 2010;54:3564-3568.
27. Calbo E, Friexas N, Xercavins M, et al. Foodborne nosocomial outbreak of SHV1 and CTX-M-15-producing Klebsiella pneumoniae: epidemiology and control. Clin Infect Dis 2011;52:743-749.
28. Gaillot O, Marueiouls C, Abachin E, et al. Nosocomial outbreak of Klebsiella pneumoniae producing SHV-5 extended-spectrum b-lactamase, originating from a contaminated ultrasonography coupling gel. J Clin Microbiol 1998;36:1357-1360.
29. Gupta A, Della-Latta P, Todd B, et al. Outbreak of extendedspectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit linked to artificial nails. Infect Control Hosp Epidemiol 2004;25:210-215.
30. Hota B. Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection? Clin Infect Dis 2004;39:1182-1189.
31. Hirai Y. Survival of bacteria under dry conditions: from a viewpoint of nosocomial infection. J Hosp Infect 1991;19:191-200.
32. Lemmen SW, Haifner H, Zolldan D, Stanzel S, Lutticken R. Distribution of multi-resistant gram-negative bacteria versus gram-positive bacteria in the hospital inanimate environment. J Hosp Infect 2004;56:191-197.
33. Kirkland KB. Taking off the gloves: toward a less dogmatic approach to the use of contact isolation. Clin Infect Dis 2009;48: 766-771.
34. Diekema DJ, Edmond MB. Look before you leap: active surveillance for multidrug-resistant organisms. Clin Infect Dis 2007;44:1101-1107.
35. Fuller C, Savage J, Besser S, et al. "The dirty hand in the latex glove": a study of hand hygiene compliance when gloves are worn. Infect Control Hosp Epidemiol 2011;32:1194-1199.
36. Wenzel RP. Minimizing surgical site infections. N Engl J Med 2010;362:75-77.
37. Gasink LB, Brennan PJ. Isolation precautions for antibioticresistant bacteria in healthcare settings. Curr Opin Infect Dis 2009;22:339-344.